Literature DB >> 10606390

Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.

I Marie1, E Hachulla, H Levesque, G Reumont, P Ducrotte, N Cailleux, P Y Hatron, B Devulder, H Courtois.   

Abstract

Esophageal involvement is considered a major cause of morbidity and an indicator of poor prognosis in polymyositis (PM) and dermatomyositis (DM). We describe 3 patients with steroid resistant PM/DM with life threatening esophageal involvement, resulting in impossible oral feeding and enteral nutrition with a gastric tube. All patients had both dramatic and rapid improvement of all clinical manifestations after initiation of intravenous immunoglobulin (IVIG) therapy. Swallowing disorders completely disappeared after the second infusion of IVIG, which permitted normal oral feeding and ablation of the gastric tube. Our findings suggest IVIG should be considered the treatment of choice in such cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606390

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Treatment of inflammatory myopathies.

Authors:  A C Cordeiro; D A Isenberg
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

Review 2.  Morbidity and mortality in adult polymyositis and dermatomyositis.

Authors:  Isabelle Marie
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

3.  Cyclosporine A as treatment of esophageal involvement in dermatomyositis.

Authors:  Sumiyuki Mii; Shiro Niiyama; Mai Kusunoki; Satoru Arai; Kensei Katsuoka
Journal:  Rheumatol Int       Date:  2006-08-10       Impact factor: 2.631

4.  [Severe dysphagia and erythrodermia in a 59-year-old man].

Authors:  M A Zuber; M Kouba; S E Rudolph; M Weller; P Hrdlicka
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 5.  Idiopathic inflammatory myopathies: a treatment update.

Authors:  Chester V Oddis
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

6.  [Organizing pneumonia revealing a polymyositis].

Authors:  Ahmed Ben Saad; Samah Joobeur; Naceur Rouetbi; Saousen Cheikh Mhamed; Néji Skhiri; Hathami Mribah; Ali El Kamel
Journal:  Pan Afr Med J       Date:  2014-10-01

Review 7.  The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics.

Authors:  Anjali Patwardhan
Journal:  Cureus       Date:  2020-02-19

8.  HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population.

Authors:  Xiang Gao; Lei Han; Lan Yuan; Yongchen Yang; Guimei Gou; Hengjuan Sun; Ling Lu; Liming Bao
Journal:  BMC Dermatol       Date:  2014-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.